Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • 610617109
    Member
    • Nov 2015
    • 10

    #1

    Problem with alignment: I can only align 10% of reads(CLIP data, tophat/bowtie)

    Dear all,

    I'm new to CLIP analysis, so I want to go through the CLIP data processing pipeline to get the knowledge how to process it and maybe in the future improve part of the pipeline.
    I got the data from GEO:GSE41288. It's a HITS-CLIP dataset where the author want to revealing miR-155-dependent AGO protein binding sites. But when I tried to align the reads to the genome mm9, I found I can only map 10% of reads back to genome using bowite or tophat. The command I use is as followed.

    tophat -p 8 --read-mismatches 5 --read-edit-dist 5 -o /output/MapResult/${name} /data/mm9/mm9 /data/miR155/FASTQ/${i}

    bowtie -n 3 -e 150 -l 20 -p 8 /data/mm9/mm9 /data/miR155/FASTQ/${i} --un /output/BowtieResult_new/${name}/${name}.not_hit.fastq > /output/BowtieResult_new/${name}/${name}.hit.sam

    I think I already set the threshold of mismatches quite high. Could someone give me some suggestions?

    Thanks

    Yue
  • 610617109
    Member
    • Nov 2015
    • 10

    #2
    I'm sorry, I found I should trim 6 nucleotides at 5 prime of the sequence.

    Comment

    • 610617109
      Member
      • Nov 2015
      • 10

      #3
      Update:
      After adapt the parameter on the datasets webpage, still I could get about 10% reads mapped to the genome. Is it normal for CLIP data?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        If this is a published data set have you tried to follow the method authors describe in their publication?

        Comment

        • 610617109
          Member
          • Nov 2015
          • 10

          #5
          Originally posted by GenoMax View Post
          If this is a published data set have you tried to follow the method authors describe in their publication?
          Yes, I use the parameter they said. They just discard 6 nucletides length barcode at the 5 prime.

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            This is a perpetual bioinformatics data reproducibility issue (assuming the directions/settings are clear and you are exactly following them).

            You are probably using the latest tophat/bowtie etc, which may not match what the authors used at the time of publication. You could go down the path of exactly matching the versions but not sure if that would be worth the trouble.

            Looks like you are going to have to re-do the analysis again.

            Comment

            • 610617109
              Member
              • Nov 2015
              • 10

              #7
              Originally posted by GenoMax View Post
              This is a perpetual bioinformatics data reproducibility issue (assuming the directions/settings are clear and you are exactly following them).

              You are probably using the latest tophat/bowtie etc, which may not match what the authors used at the time of publication. You could go down the path of exactly matching the versions but not sure if that would be worth the trouble.

              Looks like you are going to have to re-do the analysis again.
              Ok, I'll try. Thanks.

              Comment

              • blancha
                Senior Member
                • May 2013
                • 367

                #8
                You could try running fastqc, to check for the presence of any remaining adapter sequences or very low quality bases that should be trimmed before aligning.

                Comment

                • 610617109
                  Member
                  • Nov 2015
                  • 10

                  #9
                  Update:
                  After trim the fist 6 nucleotides, I try to use tophat/novoalign which is able to map junction reads. But their result is quite different. For one replicate, Tophat finds only 2 million mapped reads while novoalign will report about 15 million. So which should I believe? I use default parameter for both of them.

                  Comment

                  • GenoMax
                    Senior Member
                    • Feb 2008
                    • 7142

                    #10
                    You should be using parameters described in the original paper otherwise there is no chance of replicating the result.

                    Since you are going to do an independent analysis with your samples you should set a pipeline up that works for you. Remember to adequately describe (version numbers, settings) when you publish.

                    As an outside chance it is always possible that the original publication has an error in the analysis. You could correspond with the authors (making it clear that you are only trying to adapt their pipeline for your use) and see if they can provide some additional clarification on what is going on.

                    Comment

                    • 610617109
                      Member
                      • Nov 2015
                      • 10

                      #11
                      Originally posted by GenoMax View Post
                      You should be using parameters described in the original paper otherwise there is no chance of replicating the result.

                      Since you are going to do an independent analysis with your samples you should set a pipeline up that works for you. Remember to adequately describe (version numbers, settings) when you publish.

                      As an outside chance it is always possible that the original publication has an error in the analysis. You could correspond with the authors (making it clear that you are only trying to adapt their pipeline for your use) and see if they can provide some additional clarification on what is going on.
                      Thanks for your suggestions.
                      I'll re-read the paper again and do exactly they do.

                      Comment

                      • GenoMax
                        Senior Member
                        • Feb 2008
                        • 7142

                        #12
                        Sounds like you have spent enough time working on this data so no harm in checking with the authors. Most will be more than happy to help as long as you ask nicely.

                        Comment

                        • 610617109
                          Member
                          • Nov 2015
                          • 10

                          #13
                          Originally posted by GenoMax View Post
                          Sounds like you have spent enough time working on this data so no harm in checking with the authors. Most will be more than happy to help as long as you ask nicely.
                          Yes, I thought about it...but I'm afraid the problem is too naiive.
                          I'm e-mail to the author if I fail to map most of reads again.
                          Thank you. You're very kind.

                          Comment

                          • SylvainL
                            Senior Member
                            • Feb 2012
                            • 180

                            #14
                            Hi,

                            are you sure you have to discard only the first 6 nucleotides? Usually for CLIP, people put more nucleotides, meaning 4 N (which allow the colony recognition if it was sequenced with Illumina tech), and then the barcode...

                            Quite easy to check: just take the first 10 nucleotides of all the reads and count the different sequences you get...

                            edit: I just checked, it was sequenced with Illumina tech...
                            Last edited by SylvainL; 11-09-2015, 08:11 AM.

                            Comment

                            Latest Articles

                            Collapse

                            • SEQadmin2
                              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                              by SEQadmin2



                              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                              Despite this, “CRISPR helped turn genome editing from a specialized technique into
                              ...
                              07-31-2026, 11:01 AM
                            • SEQadmin2
                              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                              by SEQadmin2


                              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                              The systematic characterization of the human proteome has
                              ...
                              07-20-2026, 11:48 AM
                            • SEQadmin2
                              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                              by SEQadmin2



                              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                              ...
                              07-09-2026, 11:10 AM

                            ad_right_rmr

                            Collapse

                            News

                            Collapse

                            Topics Statistics Last Post
                            Started by SEQadmin2, 08-06-2026, 07:41 AM
                            0 responses
                            13 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 08-03-2026, 10:13 AM
                            0 responses
                            30 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 07-31-2026, 02:55 AM
                            0 responses
                            40 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 07-24-2026, 12:17 PM
                            0 responses
                            26 views
                            0 reactions
                            Last Post SEQadmin2  
                            Working...